arrow
A

Anna Johnston

Royal Hobart Hospital
H指数:19
被引数:1,373

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Coronavirus disease 2019 (COVID-19) risk and evolving treatment patterns in follicular lymphoma during the pandemic: Insights from the PETReA trial

2019冠状病毒病(COVID-19)大流行期间滤泡性淋巴瘤的风险及治疗模式的演变:PETReA试验的启示

2026-08-210
PRE
Body Mass Index and Clinical Associations in Australasian Lymphoma Patients: A Lymphoma and Related Diseases Registry Study

体重指数与澳大利亚及大洋洲淋巴瘤患者的临床关联:一项淋巴瘤及相关疾病登记研究

BLOOD
IF23.1
2024-11-050
PRE
Economic evaluation: immunoglobulin vs prophylactic antibiotics in hypogammaglobulinemia and hematological malignancies
2024-05-141
OAAI
Impact and utility of follicular lymphoma GELF criteria in routine care: an Australasian Lymphoma Alliance study
2024-03-074
OAAI
Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory diffuse large B-cell lymphoma
2023-08-2534
OAAI
Lenalidomide Consolidation Added to Rituximab Maintenance Therapy in Patients Remaining PET Positive After Treatment for Relapsed Follicular Lymphoma: A Phase 2 Australasian Leukaemia & Lymphoma Group NHL26 Study

在复发性滤泡性淋巴瘤治疗后PET阳性的患者中,利妥昔单抗维持治疗增加了来那度胺的巩固治疗: 一项2期澳大利亚白血病和淋巴瘤组NHL26研究

2023-03-011
OAAI
Targeting MCL-1 and BCL-2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non-Hodgkin lymphoma: Results from preclinical models and a Phase Ib study
2023-01-1715
OAAI
Management and Outcomes of Diffuse Large B-cell Lymphoma Post-transplant Lymphoproliferative Disorder in the Era of PET and Rituximab: A Multicenter Study From the Australasian Lymphoma Alliance

PET和利妥昔单抗时代弥漫性大b细胞淋巴瘤移植后淋巴增生性疾病的管理和结果: 来自澳大利亚淋巴瘤联盟的多中心研究

2021-11-013
OAAI
Outcomes of stage I/II follicular lymphoma in the PET era: an international study from the Australian Lymphoma Alliance
2019-09-3015
OA
Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation A Randomized Clinical Trial
2019-07-09149
OAAI
A multicenter retrospective comparison of induction chemoimmunotherapy regimens on outcomes in transplant-eligible patients with previously untreated mantle cell lymphoma

先前未经治疗的套细胞淋巴瘤的可移植患者的诱导化学免疫治疗方案的多中心回顾性比较

2019-05-244
OAAI